Henlius Biotech expects to raise up to $477m from Hong Kong IPO

HONG KONG (Nikkei Markets) -- Shanghai Henlius Biotech expects to raise up to HK$3.74 billion ($477 million) from an initial public offering in Hong Kong, according to sources.